PolyNovo Limited
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more
PolyNovo Limited (CALZF) - Total Liabilities
Latest total liabilities as of June 2025: $44.15 Million USD
Based on the latest financial reports, PolyNovo Limited (CALZF) has total liabilities worth $44.15 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
PolyNovo Limited - Total Liabilities Trend (1999–2025)
This chart illustrates how PolyNovo Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
PolyNovo Limited Competitors by Total Liabilities
The table below lists competitors of PolyNovo Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai Titan Scientific Co. Ltd. A
SHG:688133
|
China | CN¥2.00 Billion |
|
Clean Energy Fuels Corp
NASDAQ:CLNE
|
USA | $534.05 Million |
|
Sunny Loan Top Co Ltd
SHG:600830
|
China | CN¥3.51 Billion |
|
Hana Microelectronics Public Company Limited
PINK:HMICF
|
USA | $4.84 Billion |
|
Custom Truck One Source Inc
NYSE:CTOS
|
USA | $2.76 Billion |
|
Zhejiang Great Shengda Packaging Co Ltd
SHG:603687
|
China | CN¥866.06 Million |
|
Shandong Ruifeng Chemical Co Ltd
SHE:300243
|
China | CN¥1.27 Billion |
Liability Composition Analysis (1999–2025)
This chart breaks down PolyNovo Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PolyNovo Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PolyNovo Limited (1999–2025)
The table below shows the annual total liabilities of PolyNovo Limited from 1999 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $44.15 Million | +20.63% |
| 2024-06-30 | $36.60 Million | +34.36% |
| 2023-06-30 | $27.24 Million | +57.84% |
| 2022-06-30 | $17.26 Million | +7.94% |
| 2021-06-30 | $15.99 Million | +13.83% |
| 2020-06-30 | $14.04 Million | +559.68% |
| 2019-06-30 | $2.13 Million | +56.21% |
| 2018-06-30 | $1.36 Million | +9.65% |
| 2017-06-30 | $1.24 Million | +36.12% |
| 2016-06-30 | $913.14K | +24.66% |
| 2015-06-30 | $732.48K | -1.77% |
| 2014-06-30 | $745.71K | -6.88% |
| 2013-06-30 | $800.81K | -13.00% |
| 2012-06-30 | $920.49K | -18.61% |
| 2011-06-30 | $1.13 Million | -11.61% |
| 2010-06-30 | $1.28 Million | -12.65% |
| 2009-06-30 | $1.46 Million | +108.77% |
| 2008-06-30 | $701.69K | -42.92% |
| 2007-06-30 | $1.23 Million | -43.71% |
| 2006-06-30 | $2.18 Million | +55.49% |
| 2005-06-30 | $1.40 Million | -28.58% |
| 2004-06-30 | $1.97 Million | +62.10% |
| 2003-06-30 | $1.21 Million | +160.46% |
| 2002-06-30 | $465.76K | -42.82% |
| 2001-06-30 | $814.60K | +61.66% |
| 2000-06-30 | $503.89K | +19.22% |
| 1999-06-30 | $422.64K | -- |